{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2018, Part 2

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide information about nine drugs recently approved by the FDA.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the indications for nine newly approved drugs.
  2. Identify nursing implications for these new drugs.

Disclosures

The author and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • KY-BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Planner
Test Code: N0718A
Published: Jul 2018
Expires: 12/31/2026
Sources: Nursing2020
Required Passing Score: 18/18 (100%)
Authors: Daniel A. Hussar, PhD
Categories: Drug Therapy , Pharmacology
Specialties: Medical-Surgical, Neurology
Topics: Advanced Pharmacology Hours , Dermatitis , Drug Update , Multiple Sclerosis , Psoriasis , Skin